Fatemeh Sameni

Dr. Fatemeh Sameni


Research Focus & Metrics

Academic Career Length

6Years (2021-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
9 March 2023 in Journal of Global Antimicrobial Resistance
Verified
Journal Article
Open access
MDMasoud Dadashi
Masoud Dadashi
BHBahareh Hajikhani
Bahareh Hajikhani
NNNooshin Nazarinejad
Nooshin Nazarinejad
NNNegin Noorisepehr
Negin Noorisepehr
SYShahrooz Yazdani
Shahrooz Yazdani
FSFatemeh Sameni
Fatemeh Sameni
Stenotrophomonas maltophilia (S. maltophilia), an opportunistic pathogen, causes infection in patients undergoing immunosuppressive therapy, mechanical ventilation, or catheters, and long-term hospitalized patients. Due to its extensive resistance to various antibiotics and chemotherapeutic agents, S. maltophilia is challenging to treat. Using case reports, case series, and prevalence studies, the current study provides a systematic review and meta-analysis of antibiotic resistance profiles across clinical isolates of S. maltophilia. A systematic literature search was performed for original research articles published in Medline, Web of Science, and Embase databases from 2000 to 2022. Statistical analysis was performed using STATA 14 software to report antibiotic resistance of S. maltophilia clinical isolates worldwide. 223 studies (39 case reports/case series and 184 prevalence studies) were collected for analysis. A meta-analysis of prevalence studies demonstrated that the most antibiotic resistance worldwide was to levofloxacin, trimethoprim-sulfamethoxazole (TMP/SMX), and minocycline (14.4%, 9.2%, and 1.4%, respectively). Resistance to TMP/SMX (36.84%), levofloxacin (19.29%), and minocycline (1.75%) were the most prevalent antibiotic resistance types found in evaluated case reports/case series studies. The highest resistance rate to TMP/SMX was reported in Asia (19.29%), Europe (10.52%), and America (7.01%), respectively. Considering the high resistance to TMP/SMX, more attention should be paid to patients' drug regimens to prevent the emergence of multidrug-resistant S. maltophilia isolates.

31 August 2023 in International Journal of Microbiology
Verified
Journal Article
Open access
PDF file
FSFatemeh Sameni
Fatemeh Sameni
BHBahareh Hajikhani
Bahareh Hajikhani
AHAli Hashemi
Ali Hashemi
POParviz Owlia
Parviz Owlia
MNMohammad Niakan
Mohammad Niakan
MDMasoud Dadashi
Masoud Dadashi
Objectives. Today, Stenotrophomonas maltophilia (S. maltophilia) is a major opportunistic pathogen among hospitalized or immunocompromised patients. Antibiotic-resistant clinical isolates are increasing in several parts of the world. Various antibiotic-resistance and biofilm-forming genes are identified in this bacterium. Its capacity to form biofilms is an important virulence factor that may impact antibiotic-resistance patterns. In the current study, we evaluated the biofilm-formation capacity, antibiotic-resistance profile, and prevalence of biofilm-forming genes as well as antibiotic resistance genes among S. maltophilia isolates. Materials and Methods. In this cross-sectional study, 94 clinical S. maltophilia isolates were recovered from four tertiary-care hospitals in Iran between 2021 and 2022. The presence of the selected antibiotic-resistance genes and biofilm-forming genes was examined by polymerase chain reaction (PCR). The ability of biofilm formation was examined by microtiter plate assay. The KirbyBauer disc diffusion method was used to evaluate the trimethoprim-sulfamethoxazole (TMP-SMX), levofloxacin, and minocycline resistance. Results. S. maltophilia is mainly isolated from bloodstream infections. Notably, 98.93 of isolates were biofilm producers, of which 19.35, 60.22, and 20.43 produced strong, moderate, and weak biofilm, respectively. The frequency of biofilm genes was 100, 97.88, 96.80, and 75.53 for spgM, rmlA, smf-1, and rpfF, respectively. Isolates with the genotype of smf-1+/rmlA+/spgM+/rpfF+ were mostly strong biofilm producers. Among the antibiotic-resistance genes, the Smqnr, L1, and sul1 had the highest prevalence (76.59, 72.34, and 64.89), respectively. Antimicrobial susceptibility evaluation showed 1.06, 3.19, and 6.3 resistance to minocycline, TMP-SMX, and levofloxacin. Conclusion. The results of the current study demonstrated that S. maltophilia isolates differ in biofilm-forming ability. Moreover, smf-1, rmlA, and spgM genes were presented in all strong biofilm producers. Although the overall resistance rate to the evaluated antibiotics was high, there was no statistically significant relation between antibiotic resistance and the type of biofilm.

8 November 2023 in Sport Sciences for Health
Verified
Journal Article
Closed access
PDF file
MKMansoor Khaledi
Mansoor Khaledi
MDMohammad Darvishi
Mohammad Darvishi
FSFatemeh Sameni
Fatemeh Sameni
SSShahnaz Shahrjerdi
Shahnaz Shahrjerdi
EKEsmail Karami
Esmail Karami
POParviz Owlia
Parviz Owlia

29 May 2021 in International Journal of Enteric Pathogens
Verified
Journal Article
Open access
PDF file
FSFatemeh Sameni
Fatemeh Sameni
SSShahnaz Shahrjerdi
Shahnaz Shahrjerdi
AKArash Khorram
Arash Khorram
SYShahrooz Yazdani
Shahrooz Yazdani
BHBahareh Hajikhani
Bahareh Hajikhani
MDMasoud Dadashi
Masoud Dadashi
The pandemic of the novel human coronavirus disease 2019 (COVID‐19) has become an evolving global health issue due to the high morbidity and mortality rate. Patients who have comorbidities (e.g., diabetes, hypertension, obesity, cancer, and cardiovascular disease) are significantly at increased risk for admission into the intensive care unit, and this situation could affect the survival of the infected patients. Among the various comorbidities in this review, we focused on the diabetic patients who were highly affected because of increased viral entry into the cell via angiotensin-converting enzyme 2 (ACE2) in the respiratory system, leading to decreased immunity. Furthermore, several studies have been conducted on the beneficial effects of metformin in diabetic patients with COVID-19, but other studies have demonstrated the severe course of COVID-19 disease. Hence, further comprehensive studies are necessary in this regard. For these reasons, the prevention and management of COVID-19 in diabetic patients are essential and play a key role in reducing the fatality rate.

29 November 2021 in International Journal of Enteric Pathogens
Verified
Journal Article
Closed access
FSFatemeh Sameni
Fatemeh Sameni
NKNafiseh Khosravi-Dehaghi
Nafiseh Khosravi-Dehaghi
BHBahareh Hajikhani
Bahareh Hajikhani
MDMasoud Dadashi
Masoud Dadashi
MMMohammad Mohammadzadeh
Mohammad Mohammadzadeh
MGMona Ghazi
Mona Ghazi
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) rapidly spread worldwide and infected multiple age groups. The best way to reduce the risk of spreading new coronavirus (coronavirus disease 19, COVID-19) is the rapid and accurate identification of carriers and infected patients in society. Although several diagnostic tests are available, reverse transcription-polymerase chain reaction (RT-PCR) testing is commonly used for this purpose. In this review, various methods were introduced for the identification of COVID-19 patients using clinical manifestations, gastrointestinal symptoms, and molecular and serological diagnostic techniques. Finally, the advantages and disadvantages of diagnostic tests, including molecular and serological tests, were evaluated to identify the novel coronavirus.

30 November 2023 in International Journal of Enteric Pathogens
Verified
Journal Article
Closed access
BHBahareh Hajikhani
Bahareh Hajikhani
PSParastoo Sharifian
Parastoo Sharifian
MSMahshid Safavi
Mahshid Safavi
MGMehdi Goudarzi
Mehdi Goudarzi
FSFatemeh Sameni
Fatemeh Sameni
MDMasoud Dadashi
Masoud Dadashi
Background: Mycoplasma pneumoniae is a common cause of community-acquired pneumonia (CAP) in children and adolescents. Identifying the incidence and severity of this infection in individuals under the age of 18 can assist in improving the treatment and prevention process. Objectives: The present study aimed to evaluate the frequency of M. pneumoniae infection in young patients through a systematic review and meta-analysis. Methods: Three major databases (Medline (via PubMed), Embase, and Web of Science) were searched for research about M. pneumoniae infection in children. STATA (version 14) software was used to interpret the data. Results: Seventy-seven studies fulfilled the eligibility criteria to evaluate the prevalence of M. pneumoniae infection among children. The prevalence of this infection in young patients was 22.5%. The results revealed that children and adolescents in the age range of 10‒18 years old had the highest prevalence of M. pneumoniae (23.1%, 95% confidence interval [CI]=6.7‒39.4), followed by the 5‒10-year-old age group (21.6%, 95% CI=17.9‒25.3] and the under 5-year group (20.9%, 95% CI=16.7‒25.1). Conclusion: The global rate of M. pneumoniae infection has been gradually increasing since 2001. Finally, more extensive studies on the prevalence of M. pneumoniae infections in children throughout the world are needed to assess its exact prevalence and antibiotic resistance trend.